Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics

Significance The human placenta is a dynamic and cellular heterogeneous organ, which is critical in fetomaternal homeostasis and the development of preeclampsia. Previous work has shown that placenta-derived cell-free RNA increases during pregnancy. We applied large-scale microfluidic single-cell transcriptomic technology to comprehensively characterize cellular heterogeneity of the human placentas and identified multiple placental cell-type–specific gene signatures. Analysis of the cellular signature expression in maternal plasma enabled noninvasive delineation of the cellular dynamics of the placenta during pregnancy and the elucidation of extravillous trophoblastic dysfunction in early preeclampsia. The human placenta is a dynamic and heterogeneous organ critical in the establishment of the fetomaternal interface and the maintenance of gestational well-being. It is also the major source of cell-free fetal nucleic acids in the maternal circulation. Placental dysfunction contributes to significant complications, such as preeclampsia, a potentially lethal hypertensive disorder during pregnancy. Previous studies have identified significant changes in the expression profiles of preeclamptic placentas using whole-tissue analysis. Moreover, studies have shown increased levels of targeted RNA transcripts, overall and placental contributions in maternal cell-free nucleic acids during pregnancy progression and gestational complications, but it remains infeasible to noninvasively delineate placental cellular dynamics and dysfunction at the cellular level using maternal cell-free nucleic acid analysis. In this study, we addressed this issue by first dissecting the cellular heterogeneity of the human placenta and defined individual cell-type–specific gene signatures by analyzing more than 24,000 nonmarker selected cells from full-term and early preeclamptic placentas using large-scale microfluidic single-cell transcriptomic technology. Our dataset identified diverse cellular subtypes in the human placenta and enabled reconstruction of the trophoblast differentiation trajectory. Through integrative analysis with maternal plasma cell-free RNA, we resolved the longitudinal cellular dynamics of hematopoietic and placental cells in pregnancy progression. Furthermore, we were able to noninvasively uncover the cellular dysfunction of extravillous trophoblasts in early preeclamptic placentas. Our work showed the potential of integrating transcriptomic information derived from single cells into the interpretation of cell-free plasma RNA, enabling the noninvasive elucidation of cellular dynamics in complex pathological conditions.

[1]  Aleksandra A. Kolodziejczyk,et al.  Single Cell RNA-Sequencing of Pluripotent States Unlocks Modular Transcriptional Variation , 2015, Cell stem cell.

[2]  L. Duret,et al.  Placenta-Specific INSL4 Expression Is Mediated by a Human Endogenous Retrovirus Element1 , 2003, Biology of reproduction.

[3]  R. Romero,et al.  Pre-eclampsia part 1: current understanding of its pathophysiology , 2014, Nature Reviews Nephrology.

[4]  K. C. Chan,et al.  Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling , 2004, Journal of Medical Genetics.

[5]  F. Hsieh,et al.  Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro. , 2007, Human reproduction.

[6]  S. Fisher,et al.  Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. , 1999, The American journal of pathology.

[7]  R. Pitkin,et al.  Platelet and leukocyte counts in pregnancy. , 1979, JAMA.

[8]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[9]  J. C. Love,et al.  Seq-Well: A Portable, Low-Cost Platform for High-Throughput Single-Cell RNA-Seq of Low-Input Samples , 2017, Nature Methods.

[10]  P. Jiang,et al.  Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. , 2014, Clinical chemistry.

[11]  S. Fisher.  Why is placentation abnormal in preeclampsia? , 2015, American journal of obstetrics and gynecology.

[12]  Cole Trapnell,et al.  The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells , 2014, Nature Biotechnology.

[13]  J. Kingdom,et al.  Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[14]  Aleksandra A. Kolodziejczyk,et al.  Accounting for technical noise in single-cell RNA-seq experiments , 2013, Nature Methods.

[15]  R. Chiu,et al.  Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. , 2006, Clinical chemistry.

[16]  Wolfgang Huber,et al.  Love MI, Huber W, Anders S.. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol 15: 550 , 2014 .

[17]  S. Thibodeau,et al.  Characterization of human plasma-derived exosomal RNAs by deep sequencing , 2013, BMC Genomics.

[18]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[19]  M. Cauchi,et al.  Reference ranges for haematology parameters in pregnancy derived from patient populations. , 2008, Clinical and laboratory haematology.

[20]  N. M. Hjelm,et al.  Maternal plasma fetal DNA as a marker for preterm labour , 1998, The Lancet.

[21]  J. Mccoy,et al.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis , 2000, Nature.

[22]  R. Chiu,et al.  The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. , 2003, Clinical chemistry.

[23]  Ming Liu,et al.  Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. , 2013, Molecular aspects of medicine.

[24]  Peiyong Jiang,et al.  Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends , 2016, Proceedings of the National Academy of Sciences.

[25]  Miranda van Uitert,et al.  Differentially Expressed Genes in the Pre-Eclamptic Placenta: A Systematic Review and Meta-Analysis , 2013, PloS one.

[26]  R. Chiu,et al.  mRNA of placental origin is readily detectable in maternal plasma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Sahota,et al.  A strategy for identifying circulating placental RNA markers for fetal growth assessment , 2009, Prenatal diagnosis.

[28]  D. Roje,et al.  Trophoblast Apoptosis in Placentas from Pregnancies Complicated by Preeclampsia , 2011, Gynecologic and Obstetric Investigation.

[29]  W. Andrews,et al.  The leucocytes during pregnancy. , 1951, American journal of obstetrics and gynecology.

[30]  Matthew W. Snyder,et al.  Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin , 2016, Cell.

[31]  M. Leandro,et al.  Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study , 2016, BMC Pregnancy and Childbirth.

[32]  C. Ananth,et al.  Using ultrasound in the clinical management of placental implantation abnormalities. , 2015, American journal of obstetrics and gynecology.

[33]  Y. Long,et al.  Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre‐eclampsia , 2016, BJOG : an international journal of obstetrics and gynaecology.

[34]  Chunming Ding,et al.  Detection of the placental epigenetic signature of the maspin gene in maternal plasma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Maddocks,et al.  Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast , 2007, Prenatal diagnosis.

[36]  E. Ma,et al.  Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments , 2015, Proceedings of the National Academy of Sciences.

[37]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[38]  Amber Samuel,et al.  Can the quantity of cell‐free fetal DNA predict preeclampsia: a systematic review , 2014, Prenatal diagnosis.

[39]  I. Janssen,et al.  Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells , 2012, Expert opinion on biological therapy.

[40]  D. Coleman,et al.  A longitudinal study of leucocyte blood counts and lymphocyte responses in pregnancy: a marked early increase of monocyte-lymphocyte ratio. , 1983, Clinical and experimental immunology.

[41]  Holger Stepan,et al.  Predictive Value of the sFlt-1: PlGF Ratio in Women With Suspected Preeclampsia , 2016 .

[42]  T. Hviid,et al.  HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia , 2014, Front. Immunol..

[43]  G. Wagner,et al.  Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface. , 2017, Genome research.

[44]  J. Sugimoto,et al.  A novel human endogenous retroviral protein inhibits cell-cell fusion , 2013, Scientific Reports.

[45]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[46]  G. Burton,et al.  The placenta: a multifaceted, transient organ , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[47]  T. Mok,et al.  Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies. , 2010, Clinical chemistry.

[48]  P. Jiang,et al.  Universal Haplotype-Based Noninvasive Prenatal Testing for Single Gene Diseases. , 2017, Clinical chemistry.

[49]  D. Sahota,et al.  Increased placental apoptosis in pregnancies complicated by preeclampsia. , 2001, American journal of obstetrics and gynecology.

[50]  J. Trowsdale,et al.  NK receptor interactions with MHC class I molecules in pregnancy. , 2008, Seminars in immunology.

[51]  I. Sargent,et al.  Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. , 1999, Clinical chemistry.

[52]  Allon M. Klein,et al.  Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells , 2015, Cell.

[53]  Elizabeth J. Robertson,et al.  Single-cell RNA-seq reveals cell type-specific transcriptional signatures at the maternal–foetal interface during pregnancy , 2016, Nature Communications.

[54]  M. Koch,et al.  The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration. , 2013, Placenta.

[55]  Yama W. L. Zheng,et al.  Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus , 2010, Science Translational Medicine.

[56]  H. Matsuo,et al.  Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. , 2002, American journal of obstetrics and gynecology.

[57]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[58]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  A. Lambowitz,et al.  High-throughput sequencing of human plasma RNA by using thermostable group II intron reverse transcriptases , 2016, RNA.

[60]  Y. Iwatani,et al.  Changes in T, B, and NK Lymphocyte Subsets During and After Normal Pregnancy , 1997, American journal of reproductive immunology.

[61]  S. Fisher,et al.  A class I antigen, HLA-G, expressed in human trophoblasts. , 1990, Science.

[62]  W. Koh,et al.  Noninvasive in vivo monitoring of tissue-specific global gene expression in humans , 2014, Proceedings of the National Academy of Sciences.

[63]  Peiyong Jiang,et al.  Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. , 2013, Clinical chemistry.

[64]  I. Greer,et al.  Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy , 1998, The Lancet.

[65]  M. Longtine,et al.  Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR. , 2012, Placenta.

[66]  M. Laan,et al.  Extensive shift in placental transcriptome profile in preeclampsia and placental origin of adverse pregnancy outcomes , 2015, Scientific Reports.

[67]  J. Kingdom,et al.  Macrophage-Induced Apoptosis Limits Endovascular Trophoblast Invasion in the Uterine Wall of Preeclamptic Women , 2001, Laboratory Investigation.

[68]  P. Brown,et al.  Gene expression patterns in human placenta. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R. Romero,et al.  High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. , 2005, American journal of obstetrics and gynecology.

[70]  A. Tabor,et al.  High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery , 2012, Prenatal diagnosis.

[71]  P. Lala,et al.  Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. , 2003, Placenta.